zolpidem has been researched along with ADDH in 4 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects." | 2.55 | Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. ( Anand, S; Besag, FMC; Chan, EW; Cortese, S; Tong, H; Wong, ICK, 2017) |
| "Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency." | 2.49 | To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. ( Barrett, JR; Giaroli, G; Tracy, DK, 2013) |
| "Zolpidem is a sedative-hypnotic drug commonly used to treat sleep disorders." | 1.51 | Unexpected effect of Zolpidem in a patient with attention deficit hyperactivity disorder. ( Furuhashi, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, S | 1 |
| Tong, H | 1 |
| Besag, FMC | 1 |
| Chan, EW | 1 |
| Cortese, S | 1 |
| Wong, ICK | 1 |
| Furuhashi, Y | 1 |
| Barrett, JR | 1 |
| Tracy, DK | 1 |
| Giaroli, G | 1 |
| Blumer, JL | 1 |
| Findling, RL | 1 |
| Shih, WJ | 1 |
| Soubrane, C | 1 |
| Reed, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational Study Investigating the Experience of Patients Undergoing Active Insomnia Clinical Trials[NCT05978271] | 500 participants (Anticipated) | Observational | 2024-08-31 | Not yet recruiting | |||
| Efficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study[NCT00318448] | Phase 3 | 201 participants (Actual) | Interventional | 2006-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for zolpidem and ADDH
| Article | Year |
|---|---|
Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Eszopiclone; Glutamates; Guanfacine | 2017 |
To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Glutamates; Humans; Pyr | 2013 |
1 trial available for zolpidem and ADDH
| Article | Year |
|---|---|
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Human | 2009 |
1 other study available for zolpidem and ADDH
| Article | Year |
|---|---|
Unexpected effect of Zolpidem in a patient with attention deficit hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Feeding and Eating Disorders; Female; Humans; | 2019 |